Wellington Management Group’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$159M Buy
6,169,222
+273,774
+5% +$7.72M 0.03% 414
2026
Q2
$182M Sell
5,895,448
-194,068
-3% -$4.8M 0.03% 409
2026
Q1
$132M Buy
6,089,516
+905,007
+17% +$19.5M 0.02% 474
2025
Q4
$124M Buy
5,184,509
+3,918,220
+309% +$79.9M 0.02% 502
2025
Q3
$17.2M Buy
1,266,289
+330,268
+35% +$3.43M ﹤0.01% 1086
2025
Q2
$7.62M Sell
936,021
-146,787
-14% -$1.25M ﹤0.01% 1284
2025
Q1
$8.5M Buy
+1,082,808
New +$12.6M ﹤0.01% 1240
2019
Q4
– Sell
-2,541,117
Closed -$23.1M – 2100
2019
Q3
$23.1M Sell
2,541,117
-109,092
-4% -$877K 0.01% 924
2019
Q2
$21.1M Sell
2,650,209
-1,607,497
-38% -$16.1M ﹤0.01% 994
2019
Q1
$53.2M Sell
4,257,706
-25,628
-0.6% -$278K 0.01% 718
2018
Q4
$46.1M Sell
4,283,334
-89,345
-2% -$1.04M 0.01% 731
2018
Q3
$61M Sell
4,372,679
-25,183
-0.6% -$321K 0.01% 739
2018
Q2
$53.8M Buy
4,397,862
+2,280,917
+108% +$35.8M 0.01% 765
2018
Q1
$32.2M Buy
+2,116,945
New +$35.3M 0.01% 907

Other funds holding RCUS

Wellington Management Group's RCUS Position: Q3 2026 in Review

Wellington Management Group increased its Arcus Biosciences (RCUS) stake by 4.6% in Q3 2026, buying an estimated $7.72M and bringing the position to 6,169,222 shares worth $159M. The position accounts for 0.03% of the portfolio, ranked #414.

Wellington Management Group first reported a position in RCUS in Q1 2018 and has held it in 14 quarters since. The position peaked at $182M in Q2 2026. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

  • Wellington Management Group held 6,169,222 shares of Arcus Biosciences worth $159M as of Q3 2026.
  • Wellington Management Group bought 273,774 Arcus Biosciences shares in Q3 2026, an estimated $7.72M.
  • Arcus Biosciences made up 0.03% of Wellington Management Group's portfolio in Q3 2026, its #414 holding.
  • Wellington Management Group first reported a position in Arcus Biosciences in Q1 2018 and has held it in 14 quarters since.
  • Wellington Management Group's Arcus Biosciences position peaked at $182M in Q2 2026.
  • 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.